Correction to “Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug–drug-disease interactions: M4 contribution”

IF 3.1 3区 医学 Q2 PHARMACOLOGY & PHARMACY CPT: Pharmacometrics & Systems Pharmacology Pub Date : 2024-06-06 DOI:10.1002/psp4.13187
{"title":"Correction to “Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug–drug-disease interactions: M4 contribution”","authors":"","doi":"10.1002/psp4.13187","DOIUrl":null,"url":null,"abstract":"<p>Xu R, Liu W, Ge W, He H, Jiang Q. <i>CPT Pharmacometrics Syst Pharmacol</i>. 2023;12(8):1093-1106.</p><p>In the title page, the author affiliation “Wenyuan Liu<sup>1,3</sup> and Weihong Ge<sup>1,3</sup>” was incorrect. This should be changed to “Wenyuan Liu<sup>3</sup> and Weihong Ge<sup>3.</sup>”</p><p>We apologize for this error.</p>","PeriodicalId":10774,"journal":{"name":"CPT: Pharmacometrics & Systems Pharmacology","volume":"13 7","pages":"1279"},"PeriodicalIF":3.1000,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/psp4.13187","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CPT: Pharmacometrics & Systems Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/psp4.13187","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Xu R, Liu W, Ge W, He H, Jiang Q. CPT Pharmacometrics Syst Pharmacol. 2023;12(8):1093-1106.

In the title page, the author affiliation “Wenyuan Liu1,3 and Weihong Ge1,3” was incorrect. This should be changed to “Wenyuan Liu3 and Weihong Ge3.

We apologize for this error.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对 "基于生理学的埃多沙班药代动力学药效学母体-代谢物模型预测药物-药物-疾病相互作用:M4 的贡献"。
Xu R, Liu W, Ge W, He H, Jiang Q. CPT Pharmacometrics Syst Pharmacol.扉页中的作者单位 "刘文元1,3和葛卫红1,3 "有误,应改为 "刘文元3和葛卫红3"。应改为 "Wenyuan Liu3 and Weihong Ge3. "我们对此错误深表歉意。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.00
自引率
11.40%
发文量
146
审稿时长
8 weeks
期刊最新文献
Clinical study design strategies to mitigate confounding effects of time-dependent clearance on dose optimization of therapeutic antibodies. Exploration of the potential impact of batch-to-batch variability on the establishment of pharmacokinetic bioequivalence for inhalation powder drug products. Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertension. Issue Information Exposure-response modeling of liver fat imaging endpoints in non-alcoholic fatty liver disease populations administered ervogastat alone and co-administered with clesacostat.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1